Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Latrodectus mactans venom proteins refer to the diverse mixture of biologically active macromolecules in the venom of the black widow spider. The most studied are the latrotoxin family, notably α-latrotoxin (α-LTX), a presynaptic neurotoxin that specifically targets vertebrate neurons, causing massive neurotransmitter release and the characteristic symptoms of latrodectism. The venom also contains multiple insectotoxins (LITs), a crustacean-specific toxin (LCT), and a variety of enzymes including proteases and hyaluronidases, which aid in toxin dissemination and prey immobilization. These proteins have high molecular weight (typically ~100–140 kDa for latrotoxins) and act by forming calcium-permeable membrane pores and inducing exocytosis, leading to rapid synaptic vesicle depletion. As a group, they do not constitute a single druggable therapeutic target, but have served as molecular tools in research on neurotransmitter release, and are clinically relevant due to their toxic effects in envenomation. The term "Latrodectus mactans venom proteins" is broad and imprecise for a therapeutic target, as it encompasses many structurally and functionally distinct components, rather than a single molecule or receptor that can be selectively targeted by drugs.
Pore formation in neuronal membranes (latrotoxins); Induction of massive neurotransmitter release (presynaptic membrane exocytosis stimulation, primarily by α-latrotoxin); Enzymatic degradation of extracellular matrix (hyaluronidase/facilitate tissue penetration); Proteolytic cleavage of other venom protein precursors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Latrodectus mactans venom protein.